Two Sigma Securities’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Two Sigma Securities’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,870	Closed	-$13.6K	–	3568
2023 Q1	$13.6K	Buy	+12,870	New	+$24.4K	﹤0.01%	2412
2022 Q1	–	Sell	-737	Closed	-$8K	–	2703
2021 Q4	$8K	Sell	737 -1,021	-58%	-$14.6K	﹤0.01%	1492
2021 Q3	$31K	Buy	+1,758	New	+$29K	﹤0.01%	1430
2018 Q2	–	Sell	-4	Closed	-$40K	–	3205
2018 Q1	$40K	Buy	+4	New	+$44.8K	﹤0.01%	2525

Other funds holding NVIV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Two Sigma Securities's NVIV Position: Q2 2023 in Review

Two Sigma Securities sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2023, closing a stake of 12,870 shares — an estimated $13.6K sold.

Two Sigma Securities first reported a position in NVIV in Q1 2018 and held it in 4 quarters. The position peaked at $40K in Q1 2018. 15 funds tracked by Wall St. Rank hold NVIV as of Q2 2023.

Two Sigma Securities reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2023 after selling out during the quarter.
Two Sigma Securities sold 12,870 InVivo Therapeutics Holdings Corp shares in Q2 2023, an estimated $13.6K.
Two Sigma Securities first reported a position in InVivo Therapeutics Holdings Corp in Q1 2018 and held it in 4 quarters.
Two Sigma Securities's InVivo Therapeutics Holdings Corp position peaked at $40K in Q1 2018.
15 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.